Catheter Precision Showcases Its Innovative 3D Mapping System
Portfolio Pulse from Benzinga Newsdesk
Catheter Precision, Inc. (NYSE:VTAK) announced that its 3D Mapping system, VIVO, will be showcased at several electrophysiology conferences this fall. The company has also partnered with Precise S.r.l. to strengthen its presence in the Italian medical landscape. In addition to VIVO, Catheter Precision will also highlight its new product, LockeT, a venous stasis closure device.
October 10, 2023 | 12:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Catheter Precision's showcasing of its innovative 3D Mapping system and new product LockeT at several conferences, along with its strategic partnership with Precise S.r.l., could potentially boost its visibility and market presence.
The showcasing of Catheter Precision's innovative products at several conferences increases its visibility in the medical tech industry. This, coupled with the strategic partnership with Precise S.r.l., could potentially lead to increased market presence and, in turn, a positive impact on its stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100